SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2021-09-08 14:26
Tx date 2021-09-08
$RVV
Revive Therapeutics Ltd.
Frank, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$12,000
+25,000 vol
$0.48 each
2,066,500
Filed 2021-09-07 10:34
Tx date 2021-09-07
$RVV
Revive Therapeutics Ltd.
Frank, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$19,575
+45,000 vol
$0.435 each
2,041,500
Filed 2021-09-03 15:43
Tx date 2021-09-03
$RVV
Revive Therapeutics Ltd.
Lindzon, Andrew Stuart
4 - Director of Issuer
Holder: Margaret Lindzon TFSA (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$20,706
+52,000 vol
$0.3982 each
52,000
Filed 2021-09-03 15:34
Tx date 2019-12-18
$RVV
Revive Therapeutics Ltd.
Lindzon, Andrew Stuart
4 - Director of Issuer
Holder: Margaret Lindzon TFSA (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2021-09-03 12:25
Tx date 2021-09-03
$RVV
Revive Therapeutics Ltd.
Welsh, Derrick Alexander
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$10,250
+25,000 vol
$0.41 each
2,120,000
Filed 2021-09-02 13:50
Tx date 2021-09-02
$RVV
Revive Therapeutics Ltd.
Frank, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$19,000
+50,000 vol
$0.38 each
1,996,500
Filed 2021-08-23 14:13
Tx date 2021-08-23
$RVV
Revive Therapeutics Ltd.
Welsh, Derrick Alexander
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$21,000
+50,000 vol
$0.42 each
2,095,000
Filed 2021-07-30 16:22
Tx date 2021-07-30
$RVV
Revive Therapeutics Ltd.
Welsh, Derrick Alexander
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$22,896
+45,000 vol
$0.51 each
2,045,000
Filed 2021-06-25 16:10
Tx date 2021-06-24
$RVV
Revive Therapeutics Ltd.
Jackson, William
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$21,000
+300,000 vol
$0.07 each
500,000
Filed 2021-06-25 16:04
Tx date 2021-06-24
$RVV
Revive Therapeutics Ltd.
Jackson, William
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options

-300,000 vol
1,150,000
Filed 2021-06-24 08:42
Tx date 2021-06-21
$RVV
Revive Therapeutics Ltd.
Welsh, Derrick Alexander
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Options
50 - Grant of options
$300,000
+500,000 vol
$0.60 each
500,000
Filed 2021-06-24 08:42
Tx date 2020-03-05
$RVV
Revive Therapeutics Ltd.
Welsh, Derrick Alexander
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2021-06-22 16:12
Tx date 2021-06-21
$RVV
Revive Therapeutics Ltd.
Lindzon, Andrew Stuart
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$450,000
+750,000 vol
$0.60 each
1,250,000
Filed 2021-06-22 10:53
Tx date 2021-06-21
$RVV
Revive Therapeutics Ltd.
Scovenna, Christian
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+750,000 vol
1,250,000
Filed 2021-06-22 10:51
Tx date 2021-06-21
$RVV
Revive Therapeutics Ltd.
Jackson, William
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+750,000 vol
1,450,000
Filed 2021-06-22 10:48
Tx date 2021-06-21
$RVV
Revive Therapeutics Ltd.
Frank, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+4,000,000 vol
14,850,000
Filed 2021-03-04 18:52
Tx date 2021-03-04
$RVV
Revive Therapeutics Ltd.
Frank, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$19,000
+50,000 vol
$0.38 each
1,946,500
Filed 2021-03-04 18:51
Tx date 2021-03-04
$RVV
Revive Therapeutics Ltd.
Frank, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$4,000
+10,000 vol
$0.40 each
1,896,500
Filed 2021-03-04 18:50
Tx date 2021-03-04
$RVV
Revive Therapeutics Ltd.
Frank, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$15,800
+40,000 vol
$0.395 each
1,886,500
Filed 2021-03-04 18:49
Tx date 2021-03-04
$RVV
Revive Therapeutics Ltd.
Frank, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$4,000
+10,000 vol
$0.40 each
Filed 2021-03-04 18:49
Tx date 2021-03-04
$RVV
Revive Therapeutics Ltd.
Frank, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$9,875
+25,000 vol
$0.395 each
Filed 2021-03-04 18:48
Tx date 2021-03-04
$RVV
Revive Therapeutics Ltd.
Frank, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$4,000
+10,000 vol
$0.40 each
Filed 2021-03-04 18:47
Tx date 2021-03-04
$RVV
Revive Therapeutics Ltd.
Frank, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$9,875
+25,000 vol
$0.395 each
Filed 2021-03-03 16:15
Tx date 2021-03-03
$RVV
Revive Therapeutics Ltd.
Frank, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$6,675
+15,000 vol
$0.445 each
1,846,500
Filed 2021-03-03 16:15
Tx date 2021-03-03
$RVV
Revive Therapeutics Ltd.
Frank, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$9,000
+20,000 vol
$0.45 each
1,831,500
Filed 2021-03-03 16:14
Tx date 2021-03-03
$RVV
Revive Therapeutics Ltd.
Frank, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$11,000
+25,000 vol
$0.44 each
1,811,500
Filed 2021-03-02 14:12
Tx date 2021-03-02
$RVV
Revive Therapeutics Ltd.
Frank, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$19,000
+40,000 vol
$0.475 each
1,786,500
Filed 2021-02-23 12:25
Tx date 2021-02-18
$RVV
Revive Therapeutics Ltd.
Jackson, William
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$14,000
+200,000 vol
$0.07 each
200,000
Filed 2021-02-23 12:24
Tx date 2021-02-18
$RVV
Revive Therapeutics Ltd.
Jackson, William
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options

-200,000 vol
700,000
Filed 2021-02-22 18:36
Tx date 2013-12-30
$RVV
Revive Therapeutics Ltd.
Jackson, William
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2020-08-10 12:07
Tx date 2020-08-05
$RVV
Revive Therapeutics Ltd.
Frank, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$1,980,000
+6,000,000 vol
$0.33 each
10,850,000
Filed 2020-06-04 08:38
Tx date 2019-12-18
$RVV
Revive Therapeutics Ltd.
Herman, Joshua Jonathan
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
125,334
Filed 2020-06-04 08:36
Tx date 2019-12-18
$RVV
Revive Therapeutics Ltd.
Herman, Joshua Jonathan
4 - Director of Issuer
Holder: Carly Herman (Control or Direction)
Warrants
00 - Opening Balance-Initial SEDI Report
100,000
Filed 2020-06-04 08:33
Tx date 2019-12-27
$RVV
Revive Therapeutics Ltd.
Herman, Joshua Jonathan
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$35,000
+500,000 vol
$0.07 each
625,334
Filed 2020-06-04 08:32
Tx date 2019-12-18
$RVV
Revive Therapeutics Ltd.
Herman, Joshua Jonathan
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2020-05-26 11:05
Tx date 2020-03-05
$RVV
Revive Therapeutics Ltd.
Welsh, Derrick Alexander
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
2,000,000
Filed 2020-05-25 17:35
Tx date 2020-05-25
$RVV
Revive Therapeutics Ltd.
Marrelli, Carmelo
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+500,000 vol
570,000
Filed 2020-05-25 17:31
Tx date 2020-05-25
$RVV
Revive Therapeutics Ltd.
Frank, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+3,000,000 vol
4,850,000
Filed 2020-04-22 13:26
Tx date 2020-04-15
$RVV
Revive Therapeutics Ltd.
Scovenna, Christian
4 - Director of Issuer
Direct Ownership
Warrants
16 - Acquisition or disposition under a prospectus exemption

+1,500,000 vol
2,000,000
Filed 2020-04-22 13:24
Tx date 2020-04-15
$RVV
Revive Therapeutics Ltd.
Scovenna, Christian
4 - Director of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption
$75,000
+1,500,000 vol
$0.05 each
2,000,000
Filed 2020-03-19 07:31
Tx date 2020-03-18
$RVV
Revive Therapeutics Ltd.
Scovenna, Christian
4 - Director of Issuer
Direct Ownership
Warrants
16 - Acquisition or disposition under a prospectus exemption

+500,000 vol
500,000
Filed 2020-03-19 07:29
Tx date 2019-12-18
$RVV
Revive Therapeutics Ltd.
Scovenna, Christian
4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2020-03-19 07:29
Tx date 2020-03-18
$RVV
Revive Therapeutics Ltd.
Scovenna, Christian
4 - Director of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption
$25,000
+500,000 vol
$0.05 each
500,000
Filed 2020-03-19 07:26
Tx date 2019-12-18
$RVV
Revive Therapeutics Ltd.
Scovenna, Christian
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2020-02-11 11:04
Tx date 2020-02-07
$RVV
Revive Therapeutics Ltd.
Frank, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
38 - Redemption, retraction, cancellation, repurchase
$-81,250
-250,000 vol
$0.325 each
1,850,000
Filed 2020-02-03 14:32
Tx date 2020-02-03
$RVV
Revive Therapeutics Ltd.
Frank, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,600
+32,000 vol
$0.05 each
1,746,500
Filed 2020-02-03 14:31
Tx date 2020-02-03
$RVV
Revive Therapeutics Ltd.
Frank, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$360.00
+8,000 vol
$0.045 each
1,714,500
Filed 2020-01-08 11:36
Tx date 2020-01-07
$RVV
Revive Therapeutics Ltd.
Leon, Craig
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
38 - Redemption, retraction, cancellation, repurchase

-600,000 vol
0
Filed 2020-01-08 11:34
Tx date 2020-01-07
$RVV
Revive Therapeutics Ltd.
Chianelli, Fabio
3 - 10% Security Holder of Issuer
Direct Ownership
Options
38 - Redemption, retraction, cancellation, repurchase

-275,000 vol
0
Filed 2020-01-06 14:30
Tx date 2020-01-06
$RVV
Revive Therapeutics Ltd.
Frank, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,200
+40,000 vol
$0.055 each
1,706,500
Filed 2020-01-02 11:04
Tx date 2020-01-02
$RVV
Revive Therapeutics Ltd.
Frank, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$4,200
+70,000 vol
$0.06 each
1,666,500
Filed 2019-12-30 23:15
Tx date 2019-12-27
$RVV
Revive Therapeutics Ltd.
Lindzon, Andrew Stuart
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+500,000 vol
500,000
Filed 2019-12-30 23:12
Tx date 2019-12-18
$RVV
Revive Therapeutics Ltd.
Lindzon, Andrew Stuart
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2019-12-30 17:39
Tx date 2019-12-27
$RVV
Revive Therapeutics Ltd.
Frank, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+1,500,000 vol
2,100,000
Filed 2019-12-30 17:37
Tx date 2019-12-27
$RVV
Revive Therapeutics Ltd.
Scovenna, Christian
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+500,000 vol
500,000
Filed 2019-12-30 17:36
Tx date 2019-12-18
$RVV
Revive Therapeutics Ltd.
Scovenna, Christian
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2019-12-30 17:29
Tx date 2019-12-27
$RVV
Revive Therapeutics Ltd.
Jackson, William
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+500,000 vol
900,000
Filed 2019-12-30 10:49
Tx date 2019-12-18
$RVV
Revive Therapeutics Ltd.
Frank, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
600,000
Filed 2019-12-20 14:45
Tx date 2019-12-18
$RVV
Revive Therapeutics Ltd.
Lindzon, Andrew Stuart
4 - Director of Issuer
Holder: Margaret Lindzon RESP (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
10,700
Filed 2019-12-20 14:44
Tx date 2019-12-18
$RVV
Revive Therapeutics Ltd.
Lindzon, Andrew Stuart
4 - Director of Issuer
Holder: Aaron Lindzon (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
100,000
Filed 2019-12-20 14:44
Tx date 2019-12-18
$RVV
Revive Therapeutics Ltd.
Lindzon, Andrew Stuart
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
43,000
Filed 2019-12-18 17:38
Tx date 2019-12-18
$RVV
Revive Therapeutics Ltd.
Frank, Michael
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
1,596,500
Filed 2019-06-19 14:50
Tx date 2019-06-19
$RVV
Revive Therapeutics Ltd.
Leon, Craig
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
99 - Correction of information

+24,000 vol
1,154,000
Filed 2019-06-19 14:40
Tx date 2013-12-30
$RVV
Revive Therapeutics Ltd. (formerly, Mercury Capital II Limited)
Leon, Craig
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Rangercap Inc. (Indirect Ownership)
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
$67,500
+225,000 vol
$0.30 each
225,000
Filed 2019-06-19 14:35
Tx date 2018-06-18
$RVV
Revive Therapeutics Ltd.
Sansalone, Carlo
4 - Director of Issuer
Direct Ownership
Warrants
55 - Expiration of warrants

-125,000 vol
0
Filed 2014-01-09 21:28
Tx date 2013-12-30
$RVV
Revive Therapeutics Ltd. (formerly, Mercury Capital II Limited)
Leon, Craig
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Rangercap Inc. (Indirect Ownership)
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
$75,000
+250,000 vol
$0.30 each
Filed 2017-12-22
Tx date 2017-12-18
$RVV
Revive Therapeutics Ltd.
Chianelli, Fabio
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-3,410
-11,000 vol
$0.31 each
6,813,600
Filed 2017-12-22
Tx date 2017-12-19
$RVV
Revive Therapeutics Ltd.
Chianelli, Fabio
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-5,550
-18,500 vol
$0.30 each
6,795,100
Filed 2017-12-22
Tx date 2017-12-19
$RVV
Revive Therapeutics Ltd.
Chianelli, Fabio
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-4,960
-16,000 vol
$0.31 each
6,779,100
Filed 2017-12-22
Tx date 2017-12-20
$RVV
Revive Therapeutics Ltd.
Chianelli, Fabio
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-8,850
-29,500 vol
$0.30 each
6,749,600
Filed 2017-12-22
Tx date 2017-12-18
$RVV
Revive Therapeutics Ltd.
Chianelli, Fabio
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
54 - Exercise of warrants

-125,000 vol
0
Filed 2017-12-22
Tx date 2017-12-18
$RVV
Revive Therapeutics Ltd.
Leon, Craig
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
54 - Exercise of warrants
$22,500
+125,000 vol
$0.18 each
1,255,000
Filed 2017-12-22
Tx date 2017-12-18
$RVV
Revive Therapeutics Ltd.
Leon, Craig
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-38,750
-125,000 vol
$0.31 each
1,130,000
Filed 2017-12-22
Tx date 2017-12-18
$RVV
Revive Therapeutics Ltd.
Leon, Craig
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
54 - Exercise of warrants

-125,000 vol
0
Filed 2017-12-22
Tx date 2017-12-18
$RVV
Revive Therapeutics Ltd.
Chianelli, Fabio
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
54 - Exercise of warrants
$22,500
+125,000 vol
$0.18 each
6,874,600
Filed 2017-12-22
Tx date 2017-12-18
$RVV
Revive Therapeutics Ltd.
Chianelli, Fabio
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-15,250
-50,000 vol
$0.305 each
6,824,600
Filed 2017-06-30
Tx date 2017-06-28
$RVV
Revive Therapeutics Ltd.
Leon, Craig
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-206,800
-940,000 vol
$0.22 each
1,130,000
Filed 2017-04-12
Tx date 2017-04-10
$RVV
Revive Therapeutics Ltd.
Leon, Craig
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+150,000 vol
600,000
Filed 2017-04-12
Tx date 2017-04-10
$RVV
Revive Therapeutics Ltd.
Chianelli, Fabio
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+100,000 vol
275,000
Filed 2017-04-12
Tx date 2017-04-10
$RVV
Revive Therapeutics Ltd.
Sansalone, Carlo
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+100,000 vol
315,375
Filed 2017-04-12
Tx date 2017-04-10
$RVV
Revive Therapeutics Ltd.
Incledon, Beverly James
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+25,000 vol
45,000
Filed 2017-04-12
Tx date 2017-04-10
$RVV
Revive Therapeutics Ltd.
Jackson, William
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+150,000 vol
400,000
Filed 2017-04-12
Tx date 2017-04-10
$RVV
Revive Therapeutics Ltd.
Marrelli, Carmelo
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+40,000 vol
70,000
Filed 2016-06-20
Tx date 2016-06-17
$RVV
Revive Therapeutics Ltd.
Leon, Craig
4 - Director of Issuer
Holder: Rangercap Inc. (Control or Direction)
Rights
58 - Expiration of rights

-250,000 vol
0
Filed 2016-06-20
Tx date 2016-06-17
$RVV
Revive Therapeutics Ltd.
Sansalone, Carlo
4 - Director of Issuer
Direct Ownership
Warrants
57 - Exercise of rights

+125,000 vol
125,000
Filed 2016-06-20
Tx date 2013-05-24
$RVV
Revive Therapeutics Ltd.
Sansalone, Carlo
4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2016-06-20
Tx date 2016-06-17
$RVV
Revive Therapeutics Ltd.
Sansalone, Carlo
4 - Director of Issuer
Direct Ownership
Rights
58 - Expiration of rights

-991,666 vol
0
Filed 2016-06-20
Tx date 2016-06-17
$RVV
Revive Therapeutics Ltd.
Sansalone, Carlo
4 - Director of Issuer
Holder: NBCN Inc. ITF Carlo Sansalone (Control or Direction)
Rights
58 - Expiration of rights

-460,000 vol
0
Filed 2016-06-20
Tx date 2016-06-17
$RVV
Revive Therapeutics Ltd.
Leon, Craig
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+250,000 vol
2,070,000
Filed 2016-06-20
Tx date 2016-06-17
$RVV
Revive Therapeutics Ltd.
Chianelli, Fabio
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
57 - Exercise of rights

+125,000 vol
125,000
Filed 2016-06-20
Tx date 2016-06-17
$RVV
Revive Therapeutics Ltd.
Sansalone, Carlo
4 - Director of Issuer
Direct Ownership
Rights
57 - Exercise of rights

-250,000 vol
991,666
Filed 2016-06-20
Tx date 2013-12-30
$RVV
Revive Therapeutics Ltd.
Chianelli, Fabio
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2016-06-20
Tx date 2016-06-17
$RVV
Revive Therapeutics Ltd.
Chianelli, Fabio
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Spouse (Indirect Ownership)
Rights
58 - Expiration of rights

-121,000 vol
0
Filed 2016-06-20
Tx date 2016-06-17
$RVV
Revive Therapeutics Ltd.
Chianelli, Fabio
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights
58 - Expiration of rights

-6,249,600 vol
0
Filed 2016-06-20
Tx date 2016-06-17
$RVV
Revive Therapeutics Ltd.
Chianelli, Fabio
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights
57 - Exercise of rights

-250,000 vol
6,249,600
Filed 2016-06-20
Tx date 2016-06-17
$RVV
Revive Therapeutics Ltd.
Chianelli, Fabio
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+250,000 vol
6,749,600
Filed 2016-06-20
Tx date 2016-06-17
$RVV
Revive Therapeutics Ltd.
Sansalone, Carlo
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+250,000 vol
1,491,666
Filed 2016-06-20
Tx date 2016-06-17
$RVV
Revive Therapeutics Ltd.
Leon, Craig
4 - Director of Issuer
Direct Ownership
Warrants
57 - Exercise of rights

+125,000 vol
125,000
Filed 2016-06-20
Tx date 2013-12-30
$RVV
Revive Therapeutics Ltd.
Leon, Craig
4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2016-06-20
Tx date 2016-06-17
$RVV
Revive Therapeutics Ltd.
Leon, Craig
4 - Director of Issuer
Direct Ownership
Rights
58 - Expiration of rights

-1,570,000 vol
0
Filed 2016-06-20
Tx date 2016-06-17
$RVV
Revive Therapeutics Ltd.
Leon, Craig
4 - Director of Issuer
Direct Ownership
Rights
57 - Exercise of rights

-250,000 vol
1,570,000
Filed 2016-05-24
Tx date 2013-05-24
$RVV
Revive Therapeutics Ltd.
Sansalone, Carlo
4 - Director of Issuer
Holder: NBCN Inc. ITF Carlo Sansalone (Control or Direction)
Rights
00 - Opening Balance-Initial SEDI Report
Filed 2016-05-24
Tx date 2016-05-20
$RVV
Revive Therapeutics Ltd.
Leon, Craig
4 - Director of Issuer
Direct Ownership
Rights
56 - Grant of rights

+1,820,000 vol
1,820,000
Filed 2016-05-24
Tx date 2013-12-30
$RVV
Revive Therapeutics Ltd.
Leon, Craig
4 - Director of Issuer
Direct Ownership
Rights
00 - Opening Balance-Initial SEDI Report
Filed 2016-05-24
Tx date 2016-05-20
$RVV
Revive Therapeutics Ltd.
Leon, Craig
4 - Director of Issuer
Holder: Rangercap Inc. (Control or Direction)
Rights
56 - Grant of rights

+250,000 vol
250,000
Filed 2016-05-24
Tx date 2016-05-20
$RVV
Revive Therapeutics Ltd.
Chianelli, Fabio
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights
56 - Grant of rights

+6,499,600 vol
6,499,600
Filed 2016-05-24
Tx date 2013-12-30
$RVV
Revive Therapeutics Ltd.
Chianelli, Fabio
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights
00 - Opening Balance-Initial SEDI Report
Filed 2016-05-24
Tx date 2016-05-20
$RVV
Revive Therapeutics Ltd.
Chianelli, Fabio
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Spouse (Control or Direction)
Rights
56 - Grant of rights

+121,000 vol
121,000
Filed 2016-05-24
Tx date 2013-12-30
$RVV
Revive Therapeutics Ltd.
Chianelli, Fabio
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Spouse (Control or Direction)
Rights
00 - Opening Balance-Initial SEDI Report
Filed 2016-05-24
Tx date 2013-12-30
$RVV
Revive Therapeutics Ltd.
Leon, Craig
4 - Director of Issuer
Holder: Rangercap Inc. (Control or Direction)
Rights
00 - Opening Balance-Initial SEDI Report
Filed 2016-05-24
Tx date 2016-05-20
$RVV
Revive Therapeutics Ltd.
Sansalone, Carlo
4 - Director of Issuer
Holder: NBCN Inc. ITF Carlo Sansalone (Control or Direction)
Rights
56 - Grant of rights

+460,000 vol
460,000
Filed 2016-05-24
Tx date 2013-05-24
$RVV
Revive Therapeutics Ltd.
Sansalone, Carlo
4 - Director of Issuer
Direct Ownership
Rights
00 - Opening Balance-Initial SEDI Report
Filed 2016-05-24
Tx date 2016-05-20
$RVV
Revive Therapeutics Ltd.
Sansalone, Carlo
4 - Director of Issuer
Direct Ownership
Rights
56 - Grant of rights

+1,241,666 vol
1,241,666
Filed 2015-09-29
Tx date 2015-09-21
$RVV
Revive Therapeutics Ltd.
Sansalone, Carlo
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$740.00
+2,000 vol
$0.37 each
1,223,666
Filed 2015-09-29
Tx date 2015-09-21
$RVV
Revive Therapeutics Ltd.
Sansalone, Carlo
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,680
+4,000 vol
$0.42 each
1,227,666
Filed 2015-09-29
Tx date 2015-09-21
$RVV
Revive Therapeutics Ltd.
Sansalone, Carlo
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$6,300
+14,000 vol
$0.45 each
1,241,666
Filed 2015-06-15
Tx date 2015-06-12
$RVV
Revive Therapeutics Ltd.
Leon, Craig
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-140,000
-200,000 vol
$0.70 each
1,820,000
Filed 2015-05-25
Tx date 2015-05-15
$RVV
Revive Therapeutics Ltd.
Chianelli, Fabio
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
47 - Acquisition or disposition by gift

-500,000 vol
6,499,600
Filed 2015-04-30
Tx date 2015-04-22
$RVV
Revive Therapeutics Ltd.
Chianelli, Fabio
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately

-1,500,000 vol
6,999,600
Filed 2015-04-30
Tx date 2015-04-22
$RVV
Revive Therapeutics Ltd.
Leon, Craig
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately

+1,500,000 vol
2,020,000